NASDAQ · Medical - Pharmaceuticals

BGMS (BGMS) Stock

$0.91 +3.73% NASDAQ: BGMS Healthcare

Valuation

MetricValue
Price$0.91
Market Cap$1.99M
P/E Ratio0.17
P/B Ratio0.68
P/S Ratio1.16
EPS (TTM)$0.00
52-Week High$19.87
52-Week Low$0.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.59%
ROA-49.33%
ROCE-114.29%
Gross Margin18.36%
Operating Margin-2.38%
Net Margin-2.04%
Debt/Equity0.00
Current Ratio6.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-22.0M$-28.0M$-25.0M$-12.0M$-8.0M
Net Profit$-18.0M$-21.0M$-23.0M$-11.0M$-3.0M
EPS$-7704.00$-6840.00$-6420.00$-501.60$-6.45
Op Margin——-6060.2%-27916.3%-1128.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$43.0M$28.0M$9.0M$4.0M$8.0M
Total Liabilities$5.0M$8.0M$8.0M$6.0M$1.0M
Cash$37.0M$18.0M$3.0M$3.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

Top Premarket Gainers MT Newswires · Jun 5, 2026 Bio Green Med Solution Enters Business Combination Agreement to Acquire Future NRG MT Newswires · Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. GlobeNewswire · Jun 4, 2026 BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE GlobeNewswire · May 14, 2026 Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments GlobeNewswire · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$5.0M$0$0$2.0M$-1.0M
Net Cash Flow$3.0M$-18.0M$-15.0M$0$0
Free Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.23
EV / EBITDA-0.21
FCF Yield-101.49%
Quick Ratio5.87
Interest Coverage—
Return 1Y-92.66%
Return 3Y-99.91%
Return 5Y-99.99%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBLG $1.02 -4.21% -1.10 $1.84M 0.00%
BFRG $0.61 +4.04% -1.00 $7.11M 0.00%
BNBX $0.16 +0.00% 0.00 $210492 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%
MOVE $10.76 -0.55% -2.31 $8.16M 0.00%

About BGMS

BGMS is led by CEO Sing Ee Wong, employs 12 people, headquartered in US, publicly traded since 2025.

BGMS stock trades at $0.91 with a market capitalization of $1.99M. The stock is valued at a price-to-earnings (P/E) ratio of 0.17, price-to-book of 0.68, price-to-sales of 1.16. Over the past 52 weeks the stock has ranged between $0.60 and $19.87, and currently trades 95.4% below its 52-week high.

On profitability, BGMS generates a return on equity (ROE) of 20.59% — well above the market average, a sign of a high-quality business, return on capital employed of -114.29%, an operating margin of -2.38%, a net profit margin of -2.04%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides